BARDA Previews TACTIC Program for Threat-Agnostic CBRN Therapeutics
The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a pre-solicitation notice for a potential future project opportunity: TACTIC, or Threat-Agnostic CBRN Therapeutics. The anticipated effort would support development of therapeutics that address host dysregulation caused by chemical, biological, radiological, and nuclear, or CBRN, threats. BARDA is
BARDA Previews TACTIC Program for Threat-Agnostic CBRN Therapeutics Read More »